C (Abacavir Sulfate and Lamivudine 600 mg / 300 mg)
Pill with imprint C is Orange, Capsule-shape and has been identified as Abacavir sulfate and lamivudine 600 mg / 300 mg. It is supplied by Cipla USA Inc..
Abacavir/lamivudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Abacavir/lamivudine 600 mg / 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for C
Abacavir sulfate and lamivudine
- Imprint:
- C
- Strength:
- 600 mg / 300 mg
- Color:
- Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Cipla USA Inc.
- National Drug Code (NDC):
- 69097-0362
More about abacavir/lamivudine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 4 Reviews – Add your own review/rating
- Drug class: antiviral combinations
Consumer resources
Other brands: Epzicom
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
